Development of Karo Bio towards Clinical Trials
13 sept. 2004 04h06 HE
|
Karo Bio
HUDDINGE, Sweden, Sept. 13, 2004 (PRIMEZONE) -- Karo Bio's research operations have been re-engineered in 2004 by strengthening of the efforts in pharmacology and chemistry. With Karo Bio's expressed...
Special General Meeting of The Shareholders of Karo Bio
30 août 2004 11h01 HE
|
Karo Bio
HUDDINGE, Sweden, Aug. 30, 2004 (PRIMEZONE) -- At Karo Bio AB's special general meeting on Monday August 30, 2004 the following was resolved.
Approval of decisions on New Share Issue
The special...
Karo Bio -- Notice of Special General Meeting of the Shareholders of Karo Bio
16 août 2004 02h35 HE
|
Karo Bio
HUDDINGE, Sweden, Aug. 16, 2004 (PRIMEZONE) -- A special general meeting of the shareholders of Karo Bio Aktiebolag (publ) will be held on Monday August 30, 2004 at 4.00 pm in Strindbergsalen at...
Karo Bio -- Quarterly Report April-June 2004
13 juil. 2004 02h36 HE
|
Karo Bio
HUDDINGE, Sweden, July 13, 2004 (PRIMEZONE) -- Karo Bio:
-- Predevelopment candidate was identified in the Wyeth Pharmaceuticals
collaboration yielding milestone revenues for Karo Bio....
Karo Bio and Wyeth Extend Research Collaboration and Advance Lead Compound
18 juin 2004 02h38 HE
|
Karo Bio
HUDDINGE, Sweden, June 18, 2004 (PRIMEZONE) -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), has advanced into predevelopment a lead compound for atherosclerosis from the joint collaboration...
Bristol-Myers Squibb returns compound rights to Karo Bio
30 avr. 2004 02h57 HE
|
Karo Bio
HUDDINGE, Sweden, April 30, 2004 (PRIMEZONE) -- In the fall of 1997 Karo Bio and Bristol-Myers Squibb (BMS) initiated a drug discovery collaboration with the aim to develop novel treatments for...
Karo Bio Quarterly Report January-March 2004
23 avr. 2004 02h35 HE
|
Karo Bio
HUDDINGE, Sweden, April 23, 2004 (PRIMEZONE) -- Karo Bio:
-- Substantial progress has been made in the collaboration with Wyeth
Pharmaceuticals in the discovery of lead compounds that show...
Karo Bio's Annual General Meeting
22 avr. 2004 02h35 HE
|
Karo Bio
HUDDINGE, Sweden, April 22, 2004 (PRIMEZONE) -- At Karo Bio AB's Annual General Meeting on Wednesday April 21, 2004, the following was resolved. Dividend No dividend is to be paid for the financial...
Karo Bio: Full Year Report 2003 Quarterly Report October-December 2003
06 févr. 2004 05h48 HE
|
Karo Bio
HUDDINGE, Sweden, Feb. 06, 2004 (PRIMEZONE) -- Karo Bio:
- A preclinical milestone for a second compound was reached and a milestone payment was received in May in the Merck & Co., Inc....
Karo Bio Will Consolidate Research Operations to Sweden
18 nov. 2003 02h43 HE
|
Karo Bio
HUDDINGE, Sweden, Nov. 18, 2003 (PRIMEZONE) -- Karo Bio has decided to reduce its presence in North Carolina USA. Technologies, key projects and other research activities will be transferred...